FDA.reportPublic FDA data

0.5 ML zoster vaccine, recombinant 0.1 MG/ML

RxCUI
1986825
RxNorm name
0.5 ML zoster vaccine, recombinant 0.1 MG/ML
Display name
0.5 ML zoster vaccine, recombinant 0.1 MG/ML
Full name
0.5 ML zoster vaccine, recombinant 0.1 MG/ML
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:45

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125614ShingrixZoster Vaccine Recombinant, Adjuvanted351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0280849d-5c78-4a9d-8941-4eab429f6bd8varicella zoster virus glycoprotein E vaccine recombinant 0.1 MG/mL Injection [PSN] · 0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection [SCD] · 0.5 ML zoster vaccine, recombinant 0.1 MG/ML [SY]323These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) injectable suspension, for intramuscular use Initial U.S. Approval: 201720260213
279a251c-f4d0-4c47-b999-7ef1a45ac0d0varicella zoster virus glycoprotein E vaccine recombinant 0.1 MG/mL Injection [PSN] · 0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection [SCD] · 0.5 ML zoster vaccine, recombinant 0.1 MG/ML [SY]36These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted), suspension for intramuscular injection Initial U.S. Approval: 201720240109
e9ba0102-8cbb-4c4c-810e-292119095a8avaricella zoster virus glycoprotein E vaccine recombinant 0.1 MG/mL Injection [PSN] · 0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection [SCD] · 0.5 ML zoster vaccine, recombinant 0.1 MG/ML [SY]32These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted), suspension for intramuscular injection Initial U.S. Approval: 201720210415